J&J says its psoriasis drug superior to Novartis treatment in study

Johnson & Johnson said its drug, Tremfya, was found to be more effective than a rival medicine from Novartis AG in reducing the severity and affected area in adults with moderate-to-severe plaque psoriasis in a late-stage study.

from Reuters: Health News https://ift.tt/2UDOnk0